NICOLE GLISCHINSKI: Open Payments
NPI 1639345648 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 77 payments from 17 companies in 2025. Trend: 2023 $1,081 · 2024 $1,586 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $371 |
| Organon LLC | 12 | $132 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $88 |
| Galderma Laboratories, L.P. | 5 | $88 |
| UCB, Inc. | 3 | $75 |
| Janssen Biotech, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $42 |
Products named: RINVOQ, SKYRIZI, Cabtreo, Bimzelx, NEMLUVIO, TREMFYA, DUPIXENT, Sotyktu.
Industry payments across CO — which companies pay providers there.
